Opus Genetics Announces Inducement Grants in Compliance with Nasdaq Listing Rule 5635(c)(4): A Look into the Company’s Executive Compensation Practices
Opus Genetics Announces Equity Awards to New Employees Opus Genetics, a pioneering clinical-stage ophthalmic biopharmaceutical company, recently announced that its Board of Directors had approved equity awards under the Company’s 2021 Inducement Plan, as an incentive for two new employees who began their employment with Opus on March 13, 2025. This announcement adheres to Nasdaq…